吴小脉 - Taizhou Hospital of Zhejiang Province, Wenzhou Medical University

基本信息

浏览量：57

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 56 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Anlotinib Plus Oral Fluoropyrimidine S-1 in Refractory or Relapsed Small-Cell Lung Cancer (SALTER TRIAL): a Multicenter, Single-Arm, Phase II Trial

Wei Wang,Guixian Wu, Wujun Luo,Ling Lin,Chao Zhou, Guifei Yao, Meifang Chen,Xiaomai Wu, Ziran Chen,Junhui Ye, Haihua Yang,Dongqing Lv

BMC cancerno. 1 (2024): 1182-1182

引用0浏览0WOS引用

Pulmonary and Renal Long COVID at Two-Year Revisit

Jing Wang,Xiao Liang,Yufen Zheng,Yi Zhu,Kai Zhou,Xiaomai Wu,Rui Sun,Yifan Hu,Xiaoli Zhu,Hongbo Chi,Shanjun Chen,Mengge Lyu,Yuting Xie,Xiao Yi,Wei Liu,Xue Cai,Sainan Li,Qiushi Zhang,Chunlong Wu,Yingqiu Shi, Donglian Wang, Minfei Peng, Ying Zhang, Huafen Liu, Chao Zhang, Sheng Quan, Ziqing Kong, Zhouyang Kang, Guangjun Zhu, Hongguo Zhu, Shiyong Chen, Junbo Liang, Hai Yang, Jianxin Pang, Yicheng Fang, Haixiao Chen, Jun Li, Jiaqin Xu, Tiannan Guo, Bo Shen

iSciencepp.110344-110344, (2024)

引用0浏览0WOS引用

Assessment of the Risk and Symptoms of SARS-CoV-2 Infection Among Healthcare Workers During the Omicron Transmission Period: A Multicentric Study from Four Hospitals of Mainland China

Shuaishuai Chen,Mengyuan Chen, Qiaoming Chen, Tongtong Zhang, Bing Xu,Tao Hsin Tung,Bo Shen,Xiaomai Wu

Infection and drug resistance (2023): 3315-3328

引用0浏览0WOS引用

Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/s-1 Via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer

Xinhang Xia,Wenhu Pi, Yanli Lan,Xiaomai Wu,Dongqing Lv,Yinnan Meng,Haihua Yang,Wei Wang

Analytical cellular pathology（2022）

引用2浏览0WOS引用

Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR Mutation-Positive Lung Cancer with EFGR-TKI treatment: A Prospective, Single Arm, Phase II Study

Yangyang Shi,Hailing Xu,William Y. Raynor,Jiapei Ding,Ling Lin,Chao Zhou,Wei Wang,Yinnan Meng,Xiaomai Wu,Xiaofeng Chen,Dongqing Lv,Haihua Yang

crossref（2022）

引用0浏览0引用

Toripalimab and Anlotinib As a Maintenance Treatment for Extensive-Stage Small-Cell Lung Cancer: a Case Report

Guixian Wu,Jing Huang,Ling Lin,Shuangquan Yan,Weijia Pan,Qian Chen,Xiaomai Wu,Dongqing Lv

Immunotherapy（2022）

引用1浏览0WOS引用

The Evaluation of the Immune Status of COVID-19 Recovered Subjects with Persistent Abnormal Lung CT after One Year: A Longitudinal Cohort Study

Hongbo Chi,Kai Zhou,Liping Shen,Jiaqin Xu,Jun Li,Shiyong Chen,Xiaomai Wu,Tao-Hsin Tung,Bo Shen,Hongguo Zhu

International immunopharmacology (2022): 109019-109019

引用3浏览0WOS引用

Pulmonary and Renal Long COVID at Two-year Revisit

Research Square (Research Square) (2022)

引用0浏览0引用

Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study

Yangyang Shi,Hailing Xu,William Y Raynor,Jiapei Ding,Ling Lin,Chao Zhou,Wei Wang,Yinnan Meng,Xiaomai Wu,Xiaofeng Chen,Dongqing Lv,Haihua Yang

Life (Basel, Switzerland)no. 12 (2022)

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

Xiaomai Wu(吴小脉)

论文共 56 篇作者统计合作学者相似作者